Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SSE:600329.SS

34.65 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Omzet 7,306.7368,222.3128,249.256,907.5446,603.6526,993.8826,358.6225,689.2426,178.8227,080.5527,086.8796,010.1375,129.9264,391.8893,473.4712,880.8632,365.3382,258.4142,149.9682,517.1412,115.7562,064.2471,839.2591,521.939822.646
Kosten van de omzet 3,786.0154,604.0834,955.5924,150.4244,027.7554,046.9283,722.8343,480.0474,177.7484,990.0344,936.1874,094.0273,339.1092,825.6722,136.5621,778.1311,474.3681,467.1011,387.5731,426.3061,144.7551,188.2241,148.912940.509464.581
Brutowinst 3,520.7213,618.2283,293.6582,757.122,575.8972,946.9532,635.7892,209.1952,001.0732,090.5182,150.6921,916.111,790.8171,566.2171,336.9091,102.733890.97791.313762.3951,090.835971.001876.023690.347581.43358.065
Brutowinstmarge 0.4820.440.3990.3990.390.4210.4150.3880.3240.2950.3030.3190.3490.3570.3850.3830.3770.350.3550.4330.4590.4240.3750.3820.435
Onderzoek- en ontwikkelingskosten 154.564184.629153.147161.052149.202133.361100.92579.42666.31972.7971.00362.357.82357.94149.2620000000000
Algemene en administratieve kosten 130.76158.11580.17788.59283.885.74261.15661.41875.26691.10396.2382.95688.259100.0886.419291.449259.92322.343480.846374.321305.887299.588271.429209.955131.841
Verkoop- en marketingkosten 1,590.0991,726.7031,969.2651,556.4471,457.8781,829.061,699.2931,426.9591,266.4351,262.9931,363.4841,203.3941,106.14900.664749.219623.429519.393522.069634.602655.353582.13495.683355.268309.158186.041
Verkoop-, algemene en administratieve kosten 1,720.862,481.7922,049.4421,645.041,541.6791,914.8011,760.4491,488.3771,341.7011,354.0961,459.7141,286.3511,194.3991,000.744835.638914.878779.313844.4121,115.4481,029.674888.017795.271626.697519.113317.882
Overige kosten -929.244-145.168367.727337.849289.081332.708-0.9196.49445.46339.29118.29113.37718.75513.51449.02547.78472.31628.903-2.16832.9749.83935.7398.50211.6746.989
Bedrijfskosten 953.9952,493.1232,570.3162,143.9411,979.9622,380.8692,159.6271,851.9131,687.8541,658.9391,763.7731,576.4681,499.6621,271.2061,094.312936.035796.847861.5491,129.3251,048.566904.162809.363639.609530.458325.075
Bedrijfsresultaat 2,566.7261,096.975980.05866.676785.176759.023641.548526.36420.966499.011413.282405.024499.905271.534305.725209.02598.188-62.699-370.56681.69990.18393.549101.87281.5196.732
Bedrijfsresultaat ratio 0.3510.1330.1190.1250.1190.1090.1010.0930.0680.070.0580.0670.0970.0620.0880.0730.042-0.028-0.1720.0320.0430.0450.0550.0540.118
Totaal overige inkomsten en kosten netto 12.056-1.6120.1396.129-17.118-15.878-0.9194.64130.32638.15917.59712.038240.013-26.174111.9484.66164.76737.005-20.30523.274328.7940.0415.2112.845
Inkomen voor belasting 2,578.7831,095.364980.188872.806768.058743.145640.629531.001465.523537.171430.879417.062517.44281.633352.773255.658168.898-28.535-382.081104.97393.183122.343101.91385.56899.577
Inkomen voor belasting ratio 0.3530.1330.1190.1260.1160.1060.1010.0930.0750.0760.0610.0690.1010.0640.1020.0890.071-0.013-0.1780.0420.0440.0590.0550.0560.121
Belastingkosten 363.564126.658106.93185.92988.396107.78672.84157.7457.91179.30351.44256.47359.14615.04531.932-19.253-29.31820.5731.83311.769.27317.1967.9311.91510.955
Nettowinst 2,229.334986.707861.794769.144661.704625.569561.68476.08422.423451.443357.8351.794441.299247.65293.287257.818182.08-72.819-377.76480.78764.03286.45985.11164.44186.474
Nettowinstmarge 0.3050.120.1040.1110.10.0890.0880.0840.0680.0640.050.0590.0860.0560.0840.0890.077-0.032-0.1760.0320.030.0420.0460.0420.105
WPA (Winst Per Aandeel) 2.91.281.1210.860.810.730.620.550.60.480.480.60.330.40.350.24-0.099-0.510.0910.0720.0970.0960.0710.11
Verwaterde WPA 2.91.281.1110.860.810.730.620.550.60.480.480.60.330.40.350.24-0.099-0.510.0910.0720.0970.0960.0710.11
EBITDA 2,744.9151,261.3451,107.016991.277878.913846.187728.159613.336449.031619.275509.001499.687510.598396.998420.027409.222340.264168.512-212.473282.923238.086219.829180.414156.207111.448
EBITDA ratio 0.3760.1530.1340.1440.1330.1210.1150.1080.0730.0870.0720.0830.10.090.1210.1420.1440.075-0.0990.1120.1130.1060.0980.1030.135